Ns Partners LTD Biogen Inc. Transaction History

Ns Partners LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $1.91 Million - $2.98 Million	-8,804 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $20,887 - $26,456	-75 Reduced 0.84%	8,804 $2.65 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $7,044 - $9,211	-24 Reduced 0.27%	8,879 $3.14 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $75,697 - $107,061	-291 Reduced 3.17%	8,903 $2.44 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $50,760 - $56,855	165 Added 1.83%	9,194 $2.93 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $867,628 - $1.02 Million	3,086 Added 51.93%	9,029 $2.83 Million
Q2 2017 Aug 14, 2017	BUY	N/A	5,943	5,943 $1.61 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Ns Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Ns Partners LTD with notifications on news.